Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24

BACKGROUND: The standard-of-care treatment of patients with hepatitis C virus (HCV)-mixed cryoglobulinemia (MC) vasculitis includes pegylated interferon α (PegIFN)-α plus ribavirin and/or rituximab. About 30–40% of patients are non-responders or relapsers to such combination. OBJECTIVE: To analyse t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Saadoun, David, Resche Rigon, M, Thibault, V, Longuet, M, Pol, S, Blanc, F, Pialoux, G, Karras, A, Bazin-Karra, D, Cazorla, C, Vittecoq, D, Musset, L, Decaux, O, Ziza, J M, Lambotte, O, Cacoub, Patrice
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Publishing Group 2014
Schlagworte:
Clinical and Epidemiological Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3995244/
https://ncbi.nlm.nih.gov/pubmed/23606708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2012-202770
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge